全球脱发治疗产品市场 – 行业趋势和 2028 年预测

市场分析和见解：全球脱发治疗产品市场

预计在 2021 年至 2028 年的预测期内，脱发治疗产品市场将以 4.63% 的增长率增长。老年人口的增加、个人可支配收入的增加以及脱发治疗技术的普及率的提高可能会推动市场的增长。

脱发治疗产品是那些因某种原因而面临严重脱发的人使用的产品。如今，每三个人中就有一个人脱发。脱发的主要原因之一是秃发症，这是一种影响免疫系统的疾病。

对有效脱发治疗方案的需求不断增长是脱发治疗产品市场增长的根本原因。老年人口不断增加、研发支出增加、对各种脱发治疗产品可用性的认识不断提高以及个人可支配收入增加是脱发治疗产品市场增长的其他一些间接决定因素。脱发等慢性病病例的增加将进一步推动脱发治疗产品市场价值的增长。由于人类生活方式的不断变化而导致的压力水平不断增加，从长远来看也将创造有利可图和回报丰厚的脱发治疗产品市场增长机会。

另一方面，产品高昂的成本将对脱发治疗产品市场长期增长构成重大挑战。植发、激光疗法等替代性脱发治疗方法的普及将进一步拖累脱发治疗产品市场的增长率。

This hair loss treatment products market report provides details of new recent developments, trade regulations, import export analysis, production analysis, value chain optimization, market share, impact of domestic and localised market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographical expansions, technological innovations in the market. To gain more info on hair loss treatment products market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth. 

Hair Loss Treatment Products Market Scope and Market Size

The hair loss treatment products market is segmented on the basis of product type, disease type, distribution channel, gender and end user. The growth amongst the different segments helps you in attaining the knowledge related to the different growth factors expected to be prevalent throughout the market and formulate different strategies to help identify core application areas and the difference in your target markets.    

• On the basis of product type, the hair loss treatment products market is segmented into shampoos and conditioners, supplements and vitamins, serum and oil and others.
• On the basis of disease type, the hair loss treatment products market is segmented into alopecia areata, cicatricial alopecia, traction alopecia, alopecia totalis, alopecia universalis and others.
• On the basis of distribution channel, the home fitness equipment market is segmented into hypermarkets and supermarkets, medical/pharmacy stores, e-commerce, departmental stores, convenience stores and others.
• On the basis of gender, the hair loss treatment products market is segmented into male, female and children.
• On the basis of end user, the hair loss treatment products market is segmented into hospitals, home healthcare settings, dermatology centres and others.

Hair Loss Treatment Products Market Country Level Analysis

The hair loss treatment products market is analysed and market size, volume information is provided by country, product type, disease type, distribution channel, gender and end user as referenced above.    

The countries covered in the hair loss treatment products market report are the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, Israel, Egypt, South Africa, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America. 

北美在脱发治疗产品市场占据主导地位，并将在预测期内继续保持主导地位，美国和加拿大将成为主要贡献者。这是因为脱发人口基数不断增加。然而，亚太地区将在预测期内实现最高的复合年增长率 (CAGR)。个人可支配收入增加、全球化迅速发展、老年人口不断增加以及人们对脱发治疗产品的认识不断提高是该地区市场增长的一些主要决定因素。

脱发治疗产品市场报告的国家部分还提供了影响单个市场因素和国内市场监管变化，这些因素和变化会影响市场的当前和未来趋势。消费量、生产地点和产量、进出口分析、价格趋势分析、原材料成本、下游和上游价值链分析等数据点是用于预测单个国家市场情景的一些主要指标。此外，在提供国家数据的预测分析时，还考虑了全球品牌的存在和可用性以及它们因来自本地和国内品牌的激烈或稀少竞争而面临的挑战、国内关税和贸易路线的影响。

竞争格局和脱发治疗产品市场份额分析

脱发治疗产品市场竞争格局按竞争对手提供详细信息。详细信息包括公司概况、公司财务状况、产生的收入、市场潜力、研发投资、新市场计划、全球影响力、生产基地和设施、生产能力、公司优势和劣势、产品发布、产品宽度和广度、应用主导地位。以上提供的数据点仅与公司对脱发治疗产品市场的关注有关。

脱发治疗产品市场报告中涉及的主要参与者包括 Alès Groupe、Gerolymatos International SA、iGrow Laser、Lexington Intl., LLC.、Curallux, LLC.、Follicum AB、HCell Inc.、Freedom Laser Therapy, Inc.、Taisho Pharmaceutical Holdings Co., Ltd.、Vita-Cos-Med Klett-Loch GmbH、Vitabiotics Ltd.、WOCKHARDT、Teva Pharmaceuticals USA, Inc.、Pfizer Inc.、Par Pharmaceutical、GlaxoSmithKline plc、Dr. Reddy's Laboratories Ltd.、Abbott、Zydus Pharmaceuticals, Inc.、Johnson & Johnson Services, Inc.、Cipla Inc. 和 Sun Pharmaceutical Industries Ltd. 以及其他国内和全球参与者。市场份额数据分别针对全球、北美、欧洲、亚太地区 (APAC)、中东和非洲 (MEA) 和南美提供。DBMR 分析师了解竞争优势并为每个竞争对手分别提供竞争分析。  

SKU-63512